The HumanWare Project

A New Way to Make Cancer Cells Self-Destruct - Patrick Mehlen - CEO Netris Pharma

Méline Liu

What if cancer cells could be persuaded to self-destruct? In this episode of The HumanWare Project, we step inside the Lyon-based lab of Patrick Mehlen, CEO of Netris Pharma, to uncover a breakthrough approach to cancer treatment.

Instead of poisoning fast-growing cells, his team has found a way to “switch back on” the body’s natural self-destruct program, targeting the hidden, resistant cells that often cause relapse. Patrick traces his journey from fundamental cell biology to pioneering therapies, revealing how curiosity, persistence, and a refusal to follow the crowd led to one of the most promising developments in oncology.

Along the way, we explore common misconceptions about cancer, why prevention still matters, and how genetics, aging, and lifestyle intersect in this complex disease. The result is a conversation that challenges outdated beliefs and opens a window into the future of treatment and care.

This episode is not just about science, it’s about the human drive to serve, to imagine new possibilities, and to bring hope where fear has long dominated.

Subscribe to The HumanWare Project for more guided explorations into health, presence, and human potential.